Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -0.40%44 FCF Margin % is -42.29% as of Dec. 2025. GuruFocus rates ROCO:1295 with a GF Score™ of 44/100. The stock has 10 warning signs investors should review. Among 950 Biotechnology companies, Synbio Tech ranks better than 53.68% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Synbio Tech's Free Cash Flow for the
three
months ended in Dec. 2025 was NT$-120 Mil. Synbio Tech's Revenue for the
three
months ended in Dec. 2025 was NT$285 Mil. Therefore, Synbio Tech's FCF Margin % for the quarter that ended in Dec. 2025 was -42.29%.
The historical rank and industry rank for Synbio Tech's FCF Margin % or its related term are showing as below:
ROCO:1295'
s FCF Margin % Range Over the Past 10 Years
Min: -54.08 Med: -4.74 Max: 27.18
Current: -54.08
During the past 6 years, the highest FCF Margin % of Synbio Tech was 27.18%. The lowest was -54.08%. And the median was -4.74%.
ROCO:1295's FCF Margin % is ranked better than 53.68% of 950
companies
in the Biotechnology industry
Industry Median: -81.28
vs ROCO:1295: -54.08
Synbio Tech FCF Margin % Related Terms
Synbio Tech FCF Margin % Historical Data
* Premium members only.
The historical data trend for Synbio Tech's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1295 vs VRTX, REGN, ALNY: FCF Margin % Comparison
For the Biotechnology subindustry, Synbio Tech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Synbio Tech's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synbio Tech (ROCO:1295) has a FCF Margin % of -42.29% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Synbio Tech and its competitors. According to the industry distribution chart, Synbio Tech ranks #440 out of 950 companies in the Biotechnology industry, placing it in the top 46.3%.
Is Synbio Tech's FCF Margin % too high?
Synbio Tech's current FCF Margin % is -42.29%. Based on the distribution chart, Synbio Tech ranks #440 out of 950 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #440 out of 950 companies for FCF Margin %. This puts Synbio Tech in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Synbio Tech and its competitors. Synbio Tech's current FCF Margin % is -42.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current FCF Margin % of -42.29%. The current FCF Margin % is -42.29%. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current FCF Margin % is -42.29% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score
Get the complete analysis for ROCO:1295
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
